drugset

drugset / Trial / NCT07489885

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

NCT07489885 ↗

Phase 2 Recruiting 75 enrolled InventisBio Co., Ltd

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis

Timeline

Start: 2026-06-03
Primary completion: 2027-08
Completion: 2027-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	D-2570	Unknown	—	—

Indications